Results 141 to 150 of about 1,267,069 (198)

Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria. [PDF]

J Pers Med
Checa-Ros A, Okojie OJ, Wassouf JG, Yedean A, Hsueh WC, Hebda P, Llobell ER, Muhmenthaler GB, Tran MD, D'Marco L.   +9 more
europepmc   +1 more source

Inhibition of SGLT2 reduces blood pressure in the early phase of salt-sensitive hypertension in male Dahl-SS rats independently of changes in renal inflammation. [PDF]

Physiol Rep
Almutlaq RN, Srisomboon Y, Guntipally S, Hakeem AN, Veiga AC, Ross J, Anidu BS, Dayton A, O'Grady SM, Evans LC.   +9 more
europepmc   +1 more source

Association between albuminuria and prevalent diabetic retinopathy in type 2 diabetes: a cross-sectional study with exploratory analysis by carotid plaque status. [PDF]

Front Endocrinol (Lausanne)
Li N, Wu H, Xu M, Zhu X, Li Y, Wen J, Zhao Y, Wang J, Liu C.   +8 more
europepmc   +1 more source

Micro-albuminuria in diabetes mellitus--significance and screening.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2003
openaire   +1 more source

Selected miRNAs in Urinary Extracellular Vesicles Show Promise for Early and Specific Diagnostics of Diabetic Kidney Disease. [PDF]

J Extracell Biol
Barreiro K, Karttunen J, Valo E, Viippola E, Quintero I, Käräjämäki A, Rannikko A, Holthöfer H, Ganna A, Sandholm N, Thorn LM, Groop PH, Tuomi T, Dwivedi OP, Puhka M.   +14 more
europepmc   +1 more source

Quality of care for migrant populations with type 2 diabetes mellitus in Italy: a retrospective analysis of data from the the Italian AMD (Associations of Medical Diabetologists) annals initiative. [PDF]

Acta Diabetol
Occhipinti M, Ragusa I, Manicardi V, Bellone F, Calabrese M, Esposito L, Manicardi E, Nicolucci A, Ceriello A, Rocca A, Rossi MC, Russo G, Candido R, di Cianni G.   +13 more
europepmc   +1 more source

Diabetic kidney disease, biomarkers, and finerenone. [PDF]

Diabetes Obes Metab
Verma A, Upadhyay A.
europepmc   +1 more source

Drugs to Slow Progression of Chronic Kidney Disease: It Is a Whole New World!

Kidney Blood Press Res
Schoonmaker JA, Bhasin-Chhabra B, Abow Alkhier A, Swaminathan S, Hommos MS.   +4 more
europepmc   +1 more source

Evolving kidney disease phenotypes in type 2 diabetes: declining albuminuria and increasing isolated low eGFR. [PDF]

Clin Kidney J
De Cosmo SA, Russo G, Nicolucci A, Rossi C, Graziano G, Fioretto P, Tuccinardi D, Viazzi F, Sartore G, Muscarà A, Cuttone A, Piscitelli P, Candido R, Di Cianni G, Pontremoli R.   +14 more
europepmc   +1 more source

Current perspectives on lipid management in diabetic kidney disease: Can fibrates offer advantages over statins for renal outcomes? [PDF]

J Res Med Sci
Chitsazi MR, Safari F, Malekpour E, Mirzaei SA, Shafieyoun MH, Golafshan F, Rouzbahani H, Nekookhoo M, Noursina A, Siavash M.   +9 more
europepmc   +1 more source